Objectives

 1: Understand the eligible patient population and the efficacy data for CAR T therapy in hematologic malignancies 

 2: Become familiar with the relevant toxicities associated with CAR T cell therapy

Session date: 
Monday, February 4, 2019 - 12:30pm to 1:30pm
Speaker Name: 
Dr. Peter Ridell
Location: 
UCMC
IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.